Aptevo

$25.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.54 (-2.09%) Today

$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Aptevo and other stocks, options, and ETFs commission-free!

About APVO

Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer.

CEO

Marvin L. White

Employees

Headquarters

Seattle, Washington

Founded

2016

Market Cap

108.30M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

42.18K

High Today

$26.70

Low Today

$24.00

Open Price

$26.00

Volume

24.88K

52 Week High

$60.00

52 Week Low

$3.44

APVO Earnings

-$2.41

-$1.61

-$0.80

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, Pre-Market